These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7768270)
41. Development of a two-site immunoradiometric assay for rat/human corticotrophin-releasing factor. Application to the measurement of interleukin-1 beta-stimulated production of hypothalamic CRF in vitro. Hagan P; Tilders F; Poole S; Bristow AF J Immunol Methods; 1993 Mar; 160(1):11-8. PubMed ID: 7680697 [TBL] [Abstract][Full Text] [Related]
42. Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K Life Sci; 1987 Feb; 40(7):673-7. PubMed ID: 3492648 [TBL] [Abstract][Full Text] [Related]
43. Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro. Tsagarakis S; Rees LH; Besser GM; Grossman A Brain Res; 1989 Nov; 502(1):167-70. PubMed ID: 2819453 [TBL] [Abstract][Full Text] [Related]
44. Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Turnbull AV; Rivier C Endocrinology; 1996 Feb; 137(2):455-63. PubMed ID: 8593789 [TBL] [Abstract][Full Text] [Related]
45. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Nakagami Y; Suda T; Yajima F; Ushiyama T; Tomori N; Sumitomo T; Demura H; Shizume K Brain Res; 1986 Oct; 386(1-2):232-6. PubMed ID: 3022879 [TBL] [Abstract][Full Text] [Related]
46. The role of arginine vasopressin in interleukin-1 beta-induced adrenocorticotropin secretion in the rat. Sasaki S; Watanobe H; Takebe K Neuroimmunomodulation; 1995; 2(3):134-6. PubMed ID: 8646561 [TBL] [Abstract][Full Text] [Related]
47. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response. Raber J; Koob GF; Bloom FE Neurochem Int; 1997; 30(4-5):455-63. PubMed ID: 9106261 [TBL] [Abstract][Full Text] [Related]
48. Role of nitric oxide and carbon monoxide in modulating the ACTH response to immune and nonimmune signals. Rivier C Neuroimmunomodulation; 1998; 5(3-4):203-13. PubMed ID: 9730687 [TBL] [Abstract][Full Text] [Related]
49. Significance of nitric oxide in the stimulation of intestinal fluid absorption in the rat jejunum in vivo. Schirgi-Degen A; Beubler E Br J Pharmacol; 1995 Jan; 114(1):13-8. PubMed ID: 7712008 [TBL] [Abstract][Full Text] [Related]
50. Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: evidence for dependence upon nitric oxide production. Stefano GB; Prevot V; Beauvillain JC; Hughes TK Neurosci Lett; 1998 Nov; 256(3):167-70. PubMed ID: 9855366 [TBL] [Abstract][Full Text] [Related]
51. Prostaglandins mediate the ACTH response to interleukin-1-beta instilled into the hypothalamic median eminence. McCoy JG; Matta SG; Sharp BM Neuroendocrinology; 1994 Oct; 60(4):426-35. PubMed ID: 7824084 [TBL] [Abstract][Full Text] [Related]
52. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Navarra P; Tsagarakis S; Faria MS; Rees LH; Besser GM; Grossman AB Endocrinology; 1991 Jan; 128(1):37-44. PubMed ID: 1846105 [TBL] [Abstract][Full Text] [Related]
53. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro. Roe CM; Leitch IM; Boura AL; Smith R J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301 [TBL] [Abstract][Full Text] [Related]
54. Endothelin-1 stimulates the in vitro release of neurohypophyseal hormones, but not corticotropin-releasing hormone, via ETA receptors. Yasin S; Costa A; Navarra P; Pozzoli G; Kostoglou-Athanassiou I; Forsling M; Grossman A Neuroendocrinology; 1994 Dec; 60(6):553-8. PubMed ID: 7535387 [TBL] [Abstract][Full Text] [Related]
55. Interleukin-1 beta specifically stimulates nitric oxide production in the hypothalamus. Brunetti L; Volpe AR; Ragazzoni E; Preziosi P; Vacca M Life Sci; 1996; 58(25):PL373-7. PubMed ID: 8649215 [TBL] [Abstract][Full Text] [Related]
56. 3,4-Diaminopyridine-evoked noradrenaline release in rat hippocampal slices: facilitation by endogenous or exogenous nitric oxide. Lauth D; Hertting G; Jackisch R Brain Res; 1995 Sep; 692(1-2):174-82. PubMed ID: 8548301 [TBL] [Abstract][Full Text] [Related]
57. Interaction between nitric oxide and prostaglandin E2 pathways in pregnant rat uteri. Dong YL; Yallampalli C Am J Physiol; 1996 Mar; 270(3 Pt 1):E471-6. PubMed ID: 8638695 [TBL] [Abstract][Full Text] [Related]
58. Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Lyson K; McCann SM Neuroendocrinology; 1992 Jun; 55(6):708-13. PubMed ID: 1630586 [TBL] [Abstract][Full Text] [Related]
59. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro. Takao T; Hashimoto K; Ota Z Life Sci; 1988; 42(12):1199-203. PubMed ID: 2964553 [TBL] [Abstract][Full Text] [Related]
60. Nitric oxide and interleukin-1beta mediate noradrenergic induced corticotrophin-releasing hormone release in organotypic cultures of rat paraventricular nucleus. Hsieh CH; Li HY; Chen JC Neuroscience; 2010 Feb; 165(4):1191-202. PubMed ID: 20004705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]